Accuray Incorporated (ARAY) vs CervoMed Inc. (CRVO)

A side-by-side comparison of Accuray Incorporated and CervoMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARAY vs CRVO

growth of $100 · dividends reinvested · last 10y
ARAY -94.9% (-25.7%/yr)CRVO -100.0% (-53.4%/yr)ARAY compounded faster over this window
Log scale — wide-divergence pair
00110100Start $10020182020202220242026$5$0
ARAY CRVO

ARAY vs CRVO: by the numbers

  • •ARAY is the larger company ($31M vs $31M market cap).
  • •Both run net losses; ARAY's is the smaller (-12.24% vs -9408.76% net margin).

Metrics side by side

Valuation

MetricARAYCRVO
P/S ratio0.0895.87
P/B ratio0.751.35

Profitability

MetricARAYCRVO
Gross margin27.73%0.00%
Operating margin-6.58%0.00%
Net margin-12.24%-9408.76%
ROE-117.97%-132.18%
ROIC-10.09%-135.73%

Growth (annualized)

MetricARAYCRVO
Revenue CAGR (5Y)0.28%N/A
Total return CAGR (5Y)-39.94%-38.25%

Frequently asked

How have ARAY and CRVO total returns compared?
Over the past 10 years, ARAY delivered -25.77% and CRVO delivered -53.96% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.